Alimentiv is a global contract research organization (CRO) with a singular focus on advancing therapies for patients with gastrointestinal diseases. With over 30 years of experience, the company has established itself as a leader in GI clinical research, supporting more than 70% of IBD compounds in development. Operating as a private, profit-with-purpose company, Alimentiv channels its commercial success back into scientific research, technology, and its workforce. The company delivers full-service clinical trial solutions across multiple service lines, including clinical project management, data management, and medical leadership support.
Beta · Sourced from candidate reports
Be the first to share your experience with Alimentiv.
Your reply helps other candidates know what to expect.
